Heterogeneity of marker expression in B-cell leukemias and its diagnostic significance
Authors:
- 1 January 1986
- journal article
- research article
- Published by Elsevier in Leukemia Research
- Vol. 10 (1) , 25-28
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The antigen of mature human B cells detected by the monoclonal antibody FMC7: studies on the nature of the antigen and modulation of its expression.The Journal of Immunology, 1984
- Chronic lymphocytic leukemia and other chronic lymphoid proliferations: surface marker phenotypes and clinical correlations.Journal of Clinical Oncology, 1983
- MATURATION OF HUMAN LYMPHOCYTES-B - STUDIES WITH A PANEL OF MONOCLONAL-ANTIBODIES AGAINST MEMBRANE-ANTIGENS1983
- Characterization of B-cell type chronic lymphocytic leukemia cells by surface markers and a monoclonal antibodyThe American Journal of Medicine, 1982
- Monoclonal antibodies recognizing normal human T lymphocytes and malignant human B lymphocytes: a comparative study.The Journal of Immunology, 1981
- Heterogeneity of B-cell leukemias demonstrated by the monoclonal antibody FMC7Blood, 1981
- Human lymphocyte markers defined by antibodies derived from somatic cell hybrids. IV. A monoclonal antibody reacting specifically with a subpopulation of human B lymphocytes.The Journal of Immunology, 1981
- HETEROGENEITY OF B-CELL LEUKEMIAS DEMONSTRATED BY THE MONOCLONAL-ANTIBODY FMC71981
- Human T cell antigens defined by monoclonal antibodies: the 65,000-dalton antigen of T cells (T65) is also found on chronic lymphocytic leukemia cells bearing surface immunoglobulin.The Journal of Immunology, 1980
- An antigen shared by a human T cell subset and B cell chronic lymphocytic leukemic cells. Distribution on normal and malignant lymphoid cells.Journal of Experimental Medicine, 1980